Case 4: PARP Inhibitors for Treating BRCA+ Triple-Negative Breast Cancer

Case 4: PARP Inhibitors for Treating BRCA+ Triple-Negative Breast Cancer

Virtual Case Library: Metastatic Triple-Negative Breast CancerПодробнее

Virtual Case Library: Metastatic Triple-Negative Breast Cancer

Virtual Case Library: Metastatic Triple-Negative Breast CancerПодробнее

Virtual Case Library: Metastatic Triple-Negative Breast Cancer

Cancer Topics - Contrasting Cases: Systemic Therapy for Metastatic Triple-negative Breast CancerПодробнее

Cancer Topics - Contrasting Cases: Systemic Therapy for Metastatic Triple-negative Breast Cancer

ASCO Breast Cancer Update | Jane Meisel, MD | 2022 Review and Renew SedonaПодробнее

ASCO Breast Cancer Update | Jane Meisel, MD | 2022 Review and Renew Sedona

WEBINAR: New Treatment Options for Metastatic Breast CancerПодробнее

WEBINAR: New Treatment Options for Metastatic Breast Cancer

46th ICON Conference Day 2Подробнее

46th ICON Conference Day 2

Treatment and Issues For Triple Negative Breast Cancer-May 14, 2020Подробнее

Treatment and Issues For Triple Negative Breast Cancer-May 14, 2020

Case 4: Looking Forward in BRCA+ Metastatic TNBCПодробнее

Case 4: Looking Forward in BRCA+ Metastatic TNBC

Case 4: BRCA+ Metastatic Breast CancerПодробнее

Case 4: BRCA+ Metastatic Breast Cancer

Case 4: OlympiAD Trial for BRCA+ Metastatic TNBCПодробнее

Case 4: OlympiAD Trial for BRCA+ Metastatic TNBC

Advanced Breast Cancer: Challenges in Pathways DevelopmentПодробнее

Advanced Breast Cancer: Challenges in Pathways Development

Addressing the Role of PARP Inhibitors in Different Breast Cancer SettingsПодробнее

Addressing the Role of PARP Inhibitors in Different Breast Cancer Settings

Breast Cancer: Concepts & Direction in 2010 | Memorial Sloan KetteringПодробнее

Breast Cancer: Concepts & Direction in 2010 | Memorial Sloan Kettering

Популярное